Investment Rating - The report maintains an "Accumulate" rating for the company, indicating an expected relative performance increase of 5% to 15% over the next 6 to 12 months compared to the benchmark index [3][8]. Core Views - The company is positioned as a leader in the sports nutrition sector, benefiting from steady market growth and its own technological innovations, product advantages, and customer layout [5]. - The company has launched new products, such as "Kangbiter Probiotic Electrolyte Powder," and is expanding its production capacity to address bottlenecks in protein powder and energy gel production [5]. - The company’s revenue for Q1 2025 reached 194 million yuan, a year-on-year increase of 26%, while net profit attributable to the parent company was 12.04 million yuan, up 9.66% year-on-year [5]. - The company is focusing on product innovation and channel expansion, with significant growth in its core categories, such as protein gain products and energy gels, which saw revenue increases of 72.64% and 94.52% respectively in 2024 [5]. - The company plans to deepen its dual-track layout of "protein + energy" and enhance its digital strategy, supported by favorable policies in health and sports digitalization [5]. Summary by Sections Financial Performance - The company’s projected revenue for 2023 is 843 million yuan, with a growth rate of 33% year-on-year, and is expected to reach 1.74 billion yuan by 2026 [3]. - The net profit attributable to the parent company is forecasted to grow from 88 million yuan in 2023 to 250 million yuan by 2027, reflecting a compound annual growth rate of 33% [3]. - The company’s P/E ratio is projected to decrease from 33.2 in 2023 to 11.7 by 2027, indicating an improving valuation as earnings grow [3]. Cost and Margin Analysis - The company experienced a 47.83% increase in operating costs in Q1 2025, primarily due to high raw material prices and expanded procurement for military orders [5]. - The gross margin is expected to improve from 39.4% in 2024 to 42.9% by 2027, reflecting better cost management and product mix [7]. Investment and Expansion Plans - The company is investing in expanding its production capacity, with the second phase of its production base expected to be operational by August 2026 [5]. - The company has increased its R&D expenses by 15.45% to 8.61 million yuan in Q1 2025, indicating a commitment to enhancing its technological capabilities [5].
康比特（833429）：点评报告：营收增长成本端略有承压，产品创新蓄力长期价值